Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › MR1 restricted T cell receptors for cancer immunotherapy

MR1 restricted T cell receptors for cancer immunotherapy

US Patent 11702459 · Granted Jul 18, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Carbohydrate-glycolipid conjugate vaccines2020
Methods to inhibit intracellular growth of bacteria and to treat bacteria-mediat2017
Sulfoglycolipid antigens, their process of preparation, and their use against tu2012
Sulfoglycolipid antigens, their process of preparation, and their use against tu2012
Sulfoglycolipid antigens, their extraction from Mycobacterium tuberculosis, and 2012